Stocks
Allogene Therapeutics (ALLO) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -9.82 | 0.00 | 0.00 | -2.06 | -2.02 | -4.39 | |||
| Changes by years, y/y, % | -41% | -100% | -2% | -34.5% | |||||
Allogene Therapeutics. P/FCF
Allogene Therapeutics. P/FCF, changes, %
Allogene Therapeutics (ALLO) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | -1.59 | -1.43 | -1.73 | -2.02 | -5.35 | -4.39 | ||
| Changes by years, y/y, % | -36% | -9% | +237% | |||||
| Changes by quarters, q/q, % | -29% | -10% | +22% | +17% | +165% | |||
